Skip to main content
. 2023 Jul 31;29(8):2133–2141. doi: 10.1038/s41591-023-02465-7

Extended Data Fig. 1. PFS in the ITT population by investigator.

Extended Data Fig. 1

Kaplan-Meier curve of PFS in all patients. CAPOX, capecitabine plus oxaliplatin regimen; CI, confidence interval; HR, hazard ratio; ITT, intent-to-treat; mo., months; No., number; PFS, progression-free survival.